Uncategorized

Fetal Bovine Serum Market Shows Strong Growth by 2026| Merck KGaA, TCS Biosciences Ltd., HiMedia Laboratories, Bio-Techne

Global Fetal Bovine Serum Market

Global Fetal Bovine Serum Market, By Product (Charcoal Stripped, Chromatographic, Dialyzed FBS, Exosome Depleted, Stem Cell, Others), Application (Drug Discovery, Cell Culture Media, In Vitro Fertilization, Human & Animal Vaccine Production, Diagnostics, Others), End-User (Research & Academic Institutes, Industry), Geography (North America, South America, Europe, Asia-Pacific, Middle East and Africa) – Industry Trends and Forecast to 2026 Global fetal bovine serum market is set to rise from its initial estimated value of USD 757.75 million in 2018 to an estimated value of USD 1428.72 million by 2026, registering a CAGR of 8.25% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing demand from drug discovery and various other research applications due to its benefits in research and drug development and pharmaceutical industry.

Request for Sample of Global Fetal Bovine Serum Market Research Report @ https://databridgemarketresearch.com/request-a-sample/?dbmr=global-fetal-bovine-serum-market

Some of the major competitors currently working in the fetal bovine serum market are Thermo Fisher Scientific, GENERAL ELECTRIC COMPANY, Merck KGaA, TCS Biosciences Ltd., HiMedia Laboratories, Bio-Techne, PAN-Biotech, Rocky Mountain Biologicals, Bovogen Biologicals Pty Ltd., Tissue Culture Biologicals, Access Biologicals, Animal Technologies Inc., Nucleus Biologics, Biological Industries, Corning Incorporated, J R Scientific Inc., Moregate Biotech, Wisent Inc, and Zhejiang Tianhang Biotechnology Co. Ltd.

Fetal bovine serum is a by-product that is produced in the meat processing industries, with a number of widespread applications in pharmaceutical, and biotechnology research industries. Fetal bovine serum is obtained from the whole blood of normal bovine fetuses. It is widely used in the applications of a number of diagnostic systems and research studies with a number of different systems utilization for the same.

Market Drivers:

  • Growth in research and academic initiatives by the private and governmental sector is expected to drive the market growth
  • Increase in demand from traditional users of serum is also expected to drive the market growth

Market Restraints:

  • Decrease in cattle herd population due to the increased demand of dairy and meat products is expected to restrain the market growth
  • High cost and chances of viral presence in the product is expected to restrain the market growth

Segmentation: Global Fetal Bovine Serum Market

By Product

  • Charcoal Stripped
  • Chromatographic
  • Dialyzed Fetal Bovine Serum (FBS)
  • Exosome Depleted
  • Stem Cell
  • Embryonic Stem Cells Qualified
  • Mesenchymal Stem Cell Qualified
  • Others

By Application

  • Drug Discovery
  • Cell Culture Media
  • In Vitro Fertilization
  • Human & Animal Vaccine Production
  • Diagnostics
  • Others

By End-User

  • Research & Academic Institutes
  • Industry
  • Pharmaceutical
  • Biotech
  • Others

By Geography

  • North America
  • US.
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Rest of South America
  • Europe
  • Germany
  • France
  • United Kingdom
  • Italy
  • Spain
  • Russia
  • Turkey
  • Belgium
  • Netherlands
  • Switzerland
  • Rest of Europe
  • Asia-Pacific
  • Japan
  • China
  • South Korea
  • India
  • Australia
  • Singapore
  • Thailand
  • Malaysia
  • Indonesia
  • Philippines
  • Rest of Asia Pacific
  • Middle East & Africa
  • South Africa
  • Egypt
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Rest of Middle East & Africa

Order a Copy of Global Fetal Bovine Serum Market Report @ https://databridgemarketresearch.com/inquire-before-buying/?dbmr=global-fetal-bovine-serum-market

Key Developments in the Market:

In January 2018, Bio-Techne announced the acquisition of Atlanta Biologicals, with the acquisition aimed at expanding the product portfolio of the company and service capabilities.

In January 2017, Nucleus Biologics announced the launch of a new fetal bovine serum, with decreased risk of viral presence, hence proving effective and optimal for widespread applications in biotechnology and pharmaceutical industrial applications.

Competitive Analysis: Global Fetal Bovine Serum Market

Global fetal bovine serum market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of fetal bovine serum market for global, Europe, North America, Asia Pacific, South America and Middle East & Africa.

Reasons to Purchase this Report:

  • Current and future of global fetal bovine serum market outlook in the developed and emerging markets
  • The segment that is expected to dominate the market as well as the segment which holds highest CAGR in the forecast period
  • Regions/Countries that are expected to witness the fastest growth rates during the forecast period
  • The latest developments, market shares, and strategies that are employed by the major market players

Table of Contents –

  1. Introduction

 

  1. Market Segmentation
  2. Market Overview
  3. Executive Summary
  4. Premium Insights
  5. Global, By Component
  6. Product Type
  7. Delivery
  8. Industry Type
  9. Geography

10.1. Overview

10.2. North America

10.3. Europe

10.4. Asia-Pacific

10.5. South America

10.6. Middle East & Africa

  1. Company Landscape
  2. Company Profiles
  3. Related Reports

Access Detailed TOC @ https://databridgemarketresearch.com/toc/?dbmr=global-fetal-bovine-serum-market

Report Rating
Close